Friday - April 24, 2026

Friedreich’s Ataxia Pipeline Enters a Transformative Era with 20+ Therapies and Strong Clinical Momentum from Larimar Therapeutics, Minoryx Therapeutics, and Design Therapeutics | DelveInsight

Friedreich’s Ataxia Pipeline The Friedreich’s ataxia therapeutic landscape is undergoing a significant transformation, driven by robust clinical innovation and increasing research focus from leading biopharmaceutical companies.   Key Friedreich’s Ataxia Companies such as Larimar Therapeutics, Minoryx Therapeutics, Design Therapeutics, Solid … Continue reading

Global Ophthalmic Devices Market Set to Surpass USD 44 Billion by 2032, Driven by Rising Vision Disorders, AI Integration, and Expanding Geriatric Population | DelveInsight

Ophthalmic Devices Market The global ophthalmic devices market is entering a transformative growth phase, fueled by a surge in eye-related disorders, rapid technological innovation, and increasing global awareness around vision care. According to DelveInsight’s latest market intelligence report, the ophthalmic … Continue reading

Non-Alcoholic Fatty Liver Disease Pipeline Shows Strong Momentum as 90+ Pharma Companies in the Race | DelveInsight

DelveInsight’s, “Non-Alcoholic Fatty Liver Disease Pipeline Insight 2026” report provides comprehensive insights about 90+ companies and 100+ pipeline drugs in Non-Alcoholic Fatty Liver Disease pipeline landscape. It covers the Non Alcoholic Fatty Liver Disease pipeline drug profiles, including clinical and … Continue reading

Marginal Zone Lymphoma Clinical Trial Pipeline Expands as 50+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Marginal Zone Lymphoma Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in the Marginal Zone Lymphoma pipeline landscape. It covers the Marginal Zone Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. … Continue reading

Relapsed/Refractory Acute Myeloid Leukemia Clinical Trial Pipeline Accelerates as 50+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Relapsed/refractory acute myeloid leukemia Pipeline Insight 2026” report provides comprehensive insights about 50+ companies and 75+ pipeline drugs in Relapsed/refractory acute myeloid leukemia (AML) pipeline landscape. It covers the Relapsed/Refractory Acute Myeloid Leukemia pipeline drug profiles, including clinical and … Continue reading

Small Cell Lung Cancer Clinical Trial Pipeline Gains Momentum: 100+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Small Cell Lung Cancer Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline landscape. It covers the Small Cell Lung Cancer pipeline drug profiles, including clinical and nonclinical … Continue reading